Using human ovarian and cervical cancer cells, we previously reported that a combination of Wi-A and CAPE (1 μM and 20 μM) demonstrated a better anticancer potential as compared to each of the two compounds alone [36]. The gene discussed is SMC2; the disease is cervical carcinoma.